Opioid Drugs Market 2020 Global Share, Trend and Opportunities Forecast to 2024

Pune, India -- (SBWire) -- 07/31/2020 --Opioid Drugs Industry

Description

Wiseguyreports.Com Adds "Opioid Drugs -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024" To Its Research Database

The opioid drug market is a fragmented market with numerous small and large players. Market players are investing in the development of novel therapeutics, which is anticipated to drive the market during the forecast period.

The global opioid drug market is segmented based on the product and region.

Report Scope:

The current report offers a detailed picture of the prescription opioid drug market. Prescription opioids are included in the scope of study; illegal opioids such as heroin, which are sold in illegal market for illicit usage, are not included. The market estimation includes all branded and generic opioid drugs indicated for different therapeutic application such as pain management and opioid use disorders.

This report highlights the current and future market potential of opioid drugs along with detailed analyses of the competitive environment, regulatory scenario, pipeline analysis, technological advancement and market dynamics.

The report details market shares of opioid drugs based on product and geography. Based on product, the market is segmented into buprenorphine, fentanyl, hydrocodone, morphine, oxycodone, tramadol and others. Each product segment includes detailed analyses covering an overview of drug, mechanism of action and market insights on each drug.

By geography, the market has been segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. Detailed analyses of major countries such as the U.S., Germany, the U.K. France, Japan, China and India are covered in regional segments. For market estimates, data has been provided for the year 2017 and the base year of 2018 and forecast for 2023. Estimated values used are based on drug manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3570530-opioid-drugs-global-markets-to-2023 

Report Includes:

- 20 data tables and 38 additional tables
- An overview of the global market for opioid drugs
- Analyses of global market trends, with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Discussion of types, mode of action and receptor target of opioids drugs i.e. Mu receptor, Delta receptor and Kappa receptor
- Details of technological advancement for new opioid formulation to reduce the risk of drug abuse
- Case study of opioid addiction, opioid abuse and overdose and significant events addressing opioid misuse and abuse
- Information on stringent regulatory policies and government guidelines to impede the adoption rate of the opioid drugs
- Insights of new safety measures announced for immediate release (IR) opioids and CDC guidelines on prescribing opioids for chronic pain
- Company profiles of the major players of the market, including Acura Pharmaceuticals Inc., Cipher Pharmaceutical Inc., Daiichi Sankyo Inc., Johnson & Johnson, Lupin Ltd., Pfizer Inc., Sun Pharmaceuticals and Teva Pharmaceutical Industries Ltd.

Table of Contents 

Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Chapter 4 Market Dynamics
Chapter 5 Market Breakdown by Product
Chapter 6 Market Breakdown by Region
Chapter 7 Regulatory Environment
Chapter 8 Pipeline Analysis
Chapter 9 Competitive Landscape

Leave a Query @ https://www.wiseguyreports.com/enquiry/3570530-opioid-drugs-global-markets-to-2023

Chapter 10 Company Profiles
ACURA PHARMACEUTICALS INC.
Company Overview
Product Portfolio
ALLERGAN PLC
Company Overview
Financials
Product Portfolio
APOTEX INC.
Company Overview
Product Portfolio
ASSERTIO THERAPEUTICS INC. (DEPOMED INC.)
Company Overview
Financials
Product Portfolio
Developments and Strategies
BIODELIVERY SCIENCES INTERNATIONAL INC.
Company Overview
Financials
Product Portfolio
Developments and Strategies
CIPHER PHARMACEUTICALS INC.
Company Overview
Product Portfolio
COLLEGIUM PHARMACEUTICAL INC.
Company Overview
Product Portfolio
DAIICHI SANKYO INC.
Company Overview
Product Portfolio
EGALET CORP.
Company Overview
Product Portfolio
ENDO INTERNATIONAL PLC
Company Overview
Financials
Product Portfolio
Developments and Strategy
HIKMA PHARMACEUTICALS PLC
Company Overview
Product Portfolio
INDIVIOR PLC
Company Overview
INSYS THERAPEUTICS INC.
Company Overview
Product Portfolio
JOHNSON & JOHNSON
Company Overview
Product Portfolio
KEMPHARM INC.
Company Overview
Product Portfolio
LANNETT CO. INC.
Company Overview
Financials
Product Portfolio
LUPIN LTD.
Company Overview
Product Portfolio
MALLINCKRODT
Company Overview
Product Portfolio
MYLAN NV
Company Overview
Financials
Product Portfolio
Developments and Strategies
OREXO AB
Company Overview
Product Portfolio
PFIZER INC.
Company Overview
Product Portfolio
Developments and Strategies
PURDUE PHARMA LP
Company Overview
Product Portfolio
Developments and Strategies
PERNIX THERAPEUTICS
Company Overview
Product Portfolio
Developments and Strategies
SUN PHARMACEUTICAL INDUSTRIES LTD. (SUN PHARMA)
Company Overview
Financials
Product Portfolio
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Company Overview
Financials
Product Portfolio
Chapter 11 Appendix: Acronyms

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3570530

Continued...                       

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)